These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2801717)

  • 1. Experience with selective reporting of susceptibility to antimicrobial agents.
    Brodowy BA; Guglielmo BJ; York MK; Herfindal ET; Brooks GF
    Am J Hosp Pharm; 1989 Sep; 46(9):1816-8. PubMed ID: 2801717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Including cost data in antimicrobial agent sensitivity reports.
    Havlovic DA
    Am J Hosp Pharm; 1989 Jun; 46(6):1126. PubMed ID: 2750755
    [No Abstract]   [Full Text] [Related]  

  • 3. Computer-assisted antimicrobial-use monitoring.
    Inaraja MT; Paloma JM; Giráldez J; Idoate AJ; Hualde S
    Am J Hosp Pharm; 1986 Mar; 43(3):664-70. PubMed ID: 3754692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic cost control measures in a hospital pharmacy.
    Manzo J; Amodio-Groton MA; Kleinmann K
    Clin Ther; 1993; 15 Suppl A():37-43. PubMed ID: 8513460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of clinical and administrative strategies to reduce expenditures for antimicrobial agents.
    Hess DA; Mahoney CD; Johnson PN; Corrao WM; Fisher AE
    Am J Hosp Pharm; 1990 Mar; 47(3):585-91. PubMed ID: 2316543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personal computer-based expert system for quality assurance of antimicrobial therapy.
    Morrell R; Wasilauskas B; Winslow R
    Am J Hosp Pharm; 1993 Oct; 50(10):2067-73. PubMed ID: 8238050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory practices for reporting bacterial susceptibility tests that affect antibiotic therapy.
    Schifman RB; Pindur A; Bryan JA
    Arch Pathol Lab Med; 1997 Nov; 121(11):1168-70. PubMed ID: 9372743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial drug use monitoring by a hospital pharmacy.
    Greenlaw CW
    Am J Hosp Pharm; 1977 Aug; 34(8):835-8. PubMed ID: 900135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital restriction policy for newly marketed antimicrobial agents.
    Jeffrey LP; McCloskey WW; Rich DS; Mahoney CD
    Am J Hosp Pharm; 1986 Sep; 43(9):2230-2. PubMed ID: 3766580
    [No Abstract]   [Full Text] [Related]  

  • 10. Compliance with a restricted antimicrobial agent policy in a university hospital.
    Volger BW; Ross MB; Brunetti HR; Baumgartner DD; Therasse DG
    Am J Hosp Pharm; 1988 Jul; 45(7):1540-4. PubMed ID: 3046348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-teaching program for home intravenous antimicrobial therapy.
    Schad RF; Lucarotti RL
    Am J Hosp Pharm; 1986 Feb; 43(2):372-5. PubMed ID: 3953598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer-assisted antimicrobial surveillance in a community teaching hospital.
    Jozefiak ET; Lewicki JE; Kozinn WP
    Am J Health Syst Pharm; 1995 Jul; 52(14):1536-40. PubMed ID: 7552895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of length of stay and total hospital charges with antimicrobial regimen changes.
    Raisch DW; Bootman JL; McGhan WF
    Am J Hosp Pharm; 1988 Apr; 45(4):819-23. PubMed ID: 3132038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacy-laboratory interactions: a unique method to control antibiotic costs.
    Goff D; Thornton J
    Hosp Pharm; 1989 Jan; 24(1):26-9, 32. PubMed ID: 10291600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous metronidazole: a drug utilization review in a community hospital.
    Nessim D
    Can J Hosp Pharm; 1987 Feb; 40(1):6-11. PubMed ID: 10281259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing a hospital program to improve antimicrobial use, control bacterial resistance and contain healthcare costs: the University of Louisville experience.
    Arnold FW; Patel A; Nakamatsu R; Smith RS; Newman D; Sciortino CV; Peyrani P; Snyder J; Schulz P; Ramirez JA
    J Ky Med Assoc; 2007 Sep; 105(9):431-7. PubMed ID: 17941421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ongoing drug-use review through surveillance of serum antimicrobial-drug concentrations.
    Illsley SS
    Am J Hosp Pharm; 1988 Nov; 45(11):2380-1. PubMed ID: 3228097
    [No Abstract]   [Full Text] [Related]  

  • 18. Department of pharmacy-initiated program for streamlining empirical antibiotic therapy.
    Pastel DA; Chang S; Nessim S; Shane R; Morgan MA
    Hosp Pharm; 1992 Jul; 27(7):596-603, 614. PubMed ID: 10119188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Institution-specific versus published in vitro antimicrobial susceptibility data in making formulary decisions.
    Franson TR; DaMert GJ; Sheth NK; Wisniewski T; Cooper JE; Johnson R; Babcock JB; Hoffmann RG; Malangoni MA
    Am J Hosp Pharm; 1987 Jan; 44(1):95-101. PubMed ID: 3826095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Selection of appropriate antimicrobial agents to test and report by clinical microbiology laboratories].
    Koibuchi H; Shibuya Y; Kubo N; Kawano M; Itoh K
    Rinsho Byori; 2002 Oct; 50(10):992-9. PubMed ID: 12451681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.